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Sterol Resistance in CHO Cells
Traced to Point Mutation
in SREBP Cleavage–Activating Protein
Xianxin Hua, Axel Nohturfft, a transcription factor of the basic–helix-loop-helix–
leucine zipper family, a middle segment of approxi-Joseph L. Goldstein, and Michael S. Brown
mately 75 amino acids composed of two membrane-Department of Molecular Genetics
spanning regions separated by a short hydrophilic loopUniversity of Texas Southwestern Medical Center
of 31 amino acids, and a carboxy-terminal segment ofDallas, Texas 75235
approximately 500 amino acids that plays a regulatory
role (Yokoyama et al., 1993; Hua et al., 1993). The
SREBPs are oriented in the membranes of the endoplas-Summary
mic reticulum (ER) and nuclear envelope in a hairpin
fashion, so that the NH2-terminal and carboxy-terminalThrough expression cloning we have isolated a cDNA-
segments project into the cytosol and the 31 amino acidencoding SREBP cleavage–activating protein (SCAP),
loop projects into the lumen (Hua et al.,1995). In culturedwhich regulates cholesterol metabolism by stimulat-
cells the two SREBPs act independently, and they areing cleavage of transcription factors SREBP-1 and -2,
apparently redundant.thereby releasing them from membranes. The cDNA
In sterol-depleted cells, a two-step proteolytic pro-was isolated from Chinese hamster ovary cells with
cess releases theNH2-terminal segments of theSREBPs,a dominant mutation that renders them resistant to
which enter the nucleus and activate transcription ofsterol-mediated suppression of cholesterol synthesis
genes encoding the LDL receptor and several enzymesand uptake. Sterol resistance was traced to a G→A
in the cholesterol biosynthetic pathway, including HMGtransition at codon 443 of SCAP, changing aspartic
CoA synthase (Yokoyama et al., 1993), HMG CoA reduc-acid to asparagine. The D443N mutation enhances the
tase (Vallett et al., 1996), and farnesyl diphosphate syn-cleavage-stimulating ability of SCAP and renders it
thase (Ericsson et al., 1996). The SREBPs also activateresistant to inhibition by sterols. SCAP has multiple
genes encodingenzymes of fatty acid biosynthesis (ace-membrane-spanning regions, five of which resemble
tyl CoA carboxylase and fatty acid synthetase) and de-the sterol-sensing domain of HMG CoA reductase, an
saturation (stearoyl CoA desaturase-1; Kim and Spiegel-endoplasmic reticulum enzyme whose degradation is
man, 1996; Lopez et al., 1996; Bennett et al., 1995;accelerated by sterols. SCAP appears to be a central
Shimano et al., 1996).regulator of cholesterol metabolism in animal cells.
The two-step proteolytic release process has been
studied most thoroughly for SREBP-2 (Hua et al., 1996;
Introduction Sakai et al., 1996). The process begins when a protease
clips SREBP-2 at site 1, which is at or near an arginine
The cholesterol content of cells and plasma is controlled in the lumenal loop, thereby separating the two mem-
by a feedback system that governs the transcription of brane-spanning segments. This allows a second prote-
genes encoding enzymes of cholesterol synthesis and ase to clip the protein at site 2, which is in the middle
cell surface receptors for low density lipoprotein (LDL), of the first transmembrane segment, releasing the NH2-
a cholesterol-carrying plasma lipoprotein. This system terminal domain into the cytosol. The site 1 protease is
maintains a constant level of cholesterol in hepatocytes strictly regulated by sterols. It is active insterol-depleted
and other cells by governing the rate of cholesterol up- cells, and it is turned off when sterols accumulate. The
take from LDL as well as the rate of cholesterol synthesis site 2 protease is not regulated directly by sterols, but
(Brown and Goldstein, 1986). High fat diets elevate it can act only after the site 1 protease has acted. The
plasma LDL levels in part because they cause choles- site 2 protease requires the sequence DRSR, which is
terol to accumulate in liver cells, thereby triggering the found at the NH2-terminal side of the first transmem-
feedback system, which suppresses the synthesis of brane segment in both SREBP-1 and SREBP-2. Al-
LDL receptors (Spady et al., 1993). The decrease in LDL though SREBP-1 has not been studied in detail, all avail-
receptors reduces the efficiency of LDL uptake into the able data suggest that it is processed by the same
liver, and this is partly responsible for the resultant in- proteolytic system, at least in cultured fibroblasts (Hua
crease in plasma LDL, which leads eventually to athero- et al., 1996; Sakai et al., 1996).
sclerosis and heart attacks. Drugs that inhibit 3-hydroxy- Elucidation of the SREBP system has been aided by
3-methylglutaryl coenzyme A (HMG CoA) reductase the availability of mutant Chinese hamster ovary (CHO)
exploit the feedback system by depleting the liver of cells with defects in feedback regulation. Two broad
cholesterol, thereby triggering an increase in LDL recep- types of mutants have been isolated. One type con-
tors and a fall in plasma LDL (Goldstein et al., 1995). sists of sterol auxotrophs that cannot synthesizecholes-
Such drugs have been shown to reduce heart attacks terol or LDL receptors in response to sterol depletion
and to prolong life in humans with atherosclerosis. (Chin and Chang, 1981; Evans and Metherall, 1993).
The central molecules in the cholesterol feedback sys- These cells fail to release the NH2-terminal segment of
tem are a pair of membrane-bound transcription factors SREBP-1 or -2 from membranes because they cannot
designated sterol regulatory element binding proteins-1 cleave the SREBPs at site 2 (Sakai et al., 1996).
and -2 (SREBP-1 and -2) (Wang et al., 1994). Each The second type of mutant CHO cells are sterol-resis-
SREBP is a tripartite protein consisting of an NH2-termi- tant. They cannot turn off the synthesis of cholesterol
or LDL receptors when they are overloaded with LDL–nal segment of approximately 500 amino acids that is
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Figure 1. Immunoblot Analysis of SREBP-1
and SREBP-2 in Wild-Type CHO-7 Cells and
Mutant 25-RA Cells
On day 0, cells were set up for experiments
as described in Experimental Procedures. On
day 2, the medium was changed to medium
B containing 5% newborn calf lipoprotein-
deficient serum, 50 mM sodium mevalonate,
and 50 mM compactin, supplemented with
the indicated concentration of 25-HC. On day
3, cells were harvested and fractionated into
a nuclear extract and 105 g membrane pellet
(Sakai et al., 1996). Aliquots (60 mg protein)
were subjected to SDS–PAGE. Immunoblot
analysis was carried out with 5 mg/ml of either
IgG-2A4 (A) or IgG-7D4 (B). Filters were ex-
posed to film for 2 min (A) and 20 s (B). P
and M denote precursor and mature forms of
SREBP-1 or SREBP-2, respectively.
derived cholesterol or with hydroxylated sterols such and Chang, 1994). Building upon this observation, we
designed an expression-cloning strategy to identify theas 25-hydroxycholesterol (25-HC; Chang and Limanek,
1980; Metherall et al., 1989). The sterol-resistant cells mutant gene in the 25-RA cells. We show that the pheno-
type is caused by a gain-of-function point mutation incan be divided into two classes. Class 1 cells are sterol-
resistant because they produce a truncated form of a gene encoding a novel membrane protein that we call
SCAP (SREBP cleavage–activating protein). The mutantSREBP-2 that contains the complete NH2-terminal seg-
ment but terminates before the membrane attachment SCAP activates cleavage of SREBP at site 1, and it
renders the reaction resistant to suppression by sterols.domain (Yang et al., 1994, 1995). The truncated protein
goes directly to the nucleus without a requirement for Although wild-type SCAP can exert the same effect
when overexpressed by transfection, the mutant formproteolysis, and therefore it cannot be suppressed by
sterols. A set of three independent class 1 mutants have is much more active. The mutation that activates SCAP
is a G→A transition that changes codon 443 from aspar-been studied, and each was shown to result from a
recombination in the intron that immediately follows co- tic acid to asparagine. SCAP is a membrane protein with
multiple membrane-spanning segments, some of whichdon 460 in the SREBP-2 gene (Yang et al., 1994, 1995).
Each recombination involves a different site in the large showa highly significant resemblance to themembrane-
spanning segments of HMG CoA reductase, an enzyme3100 bp intron, but each has the same effect, namely,
to produce a form of SREBP-2 that lacks the membrane whose degradation is regulated by sterols.
attachment domain. SREBP-1 is structurally normal in
the class 1 cells, but its proteolytic processing is re- Results
duced, apparently through a regulatory effect exerted
by the constitutively truncated SREBP-2. Figure 1 shows immunoblots of nuclear extracts and
membrane fractions from wild-type CHO-7 cells andWe have recently described a second class of sterol-
resistant mutant CHO cells (Cao et al., 1996).These class 25-RA cells grown in the absence of sterols or in the
presence of varying amounts of 25-HC. The filters were2 mutant cells produce normal full-length SREBP-1 and
SREBP-2, and they proteolyze them normally, but they blotted with antibodies against SREBP-1 (Figure 1A)
or SREBP-2 (Figure 1B). In the wild-type CHO cells,cannot turn off this proteolysis in response to sterol
overload. The first such line, designated SRD-4 cells, concentrations of 25-HC as low as 0.1 mg/ml caused a
disappearance of the NH2-terminal fragments of bothwas found to have two independent defects: first, an
inability to turn off the proteolysis of SREBPs; and sec- SREBPs from the nuclear extract. We have previously
shown that this disappearance is caused by an inhibitionond, a point mutation in the gene encoding acyl–
CoA:cholesterol acyltransferase (ACAT), which abol- of cleavage at site 1 (Sakai et al., 1996). In the sterol-
treated 25-RA cells, the nuclear form of SREBP-1 wasishes enzyme activity (Cao et al., 1996). Transfection of
a cDNA encoding wild-type ACAT corrected the enzyme only slightly reduced, even at 1 mg/ml of 25-HC (Figure
1A). A similar 25-HC resistance was observed for thedeficiency, but it did not restore regulation of the proteo-
lytic processing of the SREBPs, confirming that the two nuclear form of SREBP-2 in the 25-RA cells (Figure 1B).
These data demonstrate that the 25-RA cells, like thedefects are independent.
In the current studies, we identify the molecular defect previously described SRD-4 cells (Cao et al., 1996), are
resistant to the effect of 25-HC in suppressing the cleav-in one line of class 2 sterol-resistant CHO cells, namely
the 25-RA cells isolated by Chang and Limanek (1980). age of both SREBPs.
Based on the prior evidence that the defect in theLike the SRD-4 cells, the 25-RA cells manifest defective
sterol-resistant SREBP processing, but they do not have 25-RA cells is dominant (Hasan and Chang, 1994), we
developed an expression-cloning strategy to identify thea defect in ACAT. Hasan and Chang (1994) showed that
the phenotype of the25-RA cells is semidominant. When mutant gene. A cDNA library was prepared from 25-RA
cells in an expression vector that uses thecytomegalovi-they fused 25-RA cells to wild-type CHO cells, the resul-
tant hybrids were partially resistant to 25-HC (Hasan rus (CMV) promoter. The cDNAs were divided into pools
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of about 1,000 each and transfected into human kidney
293 cells, together with a reporter gene encoding lucifer-
ase under control of a promoter that contains three
copies of a sterol regulatory element (SRE-1) in tandem
with three copies of a weak binding site for the ubiqui-
tous transcription factor Sp1. This configuration, which
is based on the LDL receptor promoter/enhancer ele-
ments, has been shown to yield high level expression
that is dependent on nuclear SREBPs (Briggs et al.,
1993). After transfection, the 293 cells were incubated
in the presence of 25-HC, which suppresses luciferase
transcription by inhibiting the proteolytic release of
SREBPs. As a control for variations in transfection effi-
ciency, we also cotransfected a plasmid encoding
b-galactosidase under control of the nonregulated SV40
promoter. If the 293 cells express a cDNA that abolishes
25-HC–mediated suppression, the result should be an
increase in the ratio of luciferase to b-galactosidase
activity. This ratio is hereafter designated as “normal-
ized” luciferase activity.
Figure 2A shows a result of one transfection experi-
ment using a subset of the cDNA pools from the 25-
RA library. Normalized luciferase activity was low in all
cases except for cells that received cDNA from pool 60.
This pool of 1,000 plasmids was subfractionated into
subpools of about 100 plasmids each, and two positive
subpools were detected (Figure 2B). We chose one of
these (subpool 60-19) and further fractionated it into
subpools of approximately 10 colonies each. Again, two
positive subpools were identified, and we chose sub-
pool 60-19-42 (Figure 2C). Further fractionation steps
yielded subpool 60-19-42-23 (Figure 2D) and finally two
pure cDNA clones designated p28 and p30 (Figure 2E).
Partial sequence analysis of plasmids p28 and p30
indicated that they encoded the same protein, and we
chose to study plasmid p30 in detail. Plasmid p30 con-
tains a cDNA insert of 4.2 kb. Northern blot analysis
showed a single 4.2 kb band in the RNA from bothCHO-7
and 25-RA cells (data not shown). Complete sequence
analysis revealed that this insert encodes a full-length
copy of a 1276 amino acid protein that we named SCAP.
The insert also contains 119 bp of 59-untranslated region
and approximately 150 bp of 39-untranslated region, in-
cluding a long poly(A)1 sequence.
Figure 2. Screening Assays for Expression of SRE-1–Driven Lucifer-
We isolated a cDNA copy of wild-type SCAP from ase Reporter Gene in Transfected 293 Cells
CHO-7 cells as described in Experimental Procedures. Pools, subpools, and single clones of cDNA plasmids were tran-
The plasmids encoding the 25-RA copy of SCAP and siently transfected into 293 cells together with pSRE-Luc and pSVb,
the wild-type copy were sequenced in their entirety, and as described in Experimental Procedures. Transfections of each
pool, subpool, or single clone were done in duplicate wells (closedthe nucleotides in the coding region were compared.
and open bars) of 12 well plates. The total number of pools thatThe predicted sequence of the wild-type protein is
were transfected is denoted at the top of each panel.shown in Figure 3.
(A) 29 of 235 pools, each containing 1 3 103 independent cDNAs
A search of genome databases initially revealed a from the 25-RA cell cDNA library, were transfected into 293 cells
strong resemblance between hamster SCAP and a puta- and assayed for luciferase and b-galactosidase activity. Luciferase
tive protein encoded by a segment of Caenorhabditis activity (relative light units) was normalized to b-galactosidase activ-
ity (O.D.).elegans genomic DNA that was sequenced by Wilson
(B–D) The indicated subpools were subdivided, transfected, andet al. (1994) as part of a 2.2 Mb contiguous sequence.
assayed.While the current studies were in progress, Nagase et
(E) Single colonies from subpool number 60-19-42-23 wereal. (1996) reported the sequence of the human version
transfected and assayed.
of hamster SCAP, which they isolated as one of 40 un-
identified coding sequences from a cDNA library pre-
protein (Wilson et al., 1994). The hamster and humanpared from myeloblast KG-1 cells. Figure 3 compares
proteins are 92% identical, and the C. elegans protein isthe sequences of hamster SCAP (this study), human
SCAP (Nagase et al., 1996), and the related C. elegans 26% identical to that of the hamster. Regions of identity
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extend throughout the sequence. We found two differ-
ences between the sequence of the wild-type hamster
cDNA and the cDNA isolated from 25-RA cells. The first
was a G→A transition in codon 443, which changes the
wild-type aspartic acid to an asparagine in the 25-RA
cDNA (indicated by an asterisk in Figure 3). This aspartic
acid is conserved in the human and C. elegans se-
quences. The second difference was a G→A transition
in codon 816, which changed a glycine to arginine. Anal-
ysis of genomic DNA from wild-type CHO-7 and CHO-
K1 cells, as well as from mutant 25-RA cells, showed
that all three cell lines were heterozygous at this site
(data not shown), suggesting that it represents a silent
polymorphism. We therefore directed our attention to
the D443N mutation.
To confirm the mutation at codon 443 in the 25-RA
cells, we amplified the genomic sequence that includes
this codon from genomic DNA and cut the amplified
products with PvuI. The wild-type sequence is expected
to be cut with this enzyme, while the mutant should be
resistant (Figure 4A). Figure 4B shows that the amplified
product from wild-type CHO cells (CHO-K1 cells) was
completely cut with PvuI, whereas only about 50% of
the amplified product from the 25-RA cells was cut. This
result indicates that the 25-RA cells, but not the parental
CHO cells, are heterozygous for the D443N mutation.
Sequencing of the polymerase chain reaction (PCR)
product confirmed the D443N mutation.
The mutation in the 25-RA cells was also apparent
when we analyzed genomic DNA by single-strand con-
formational polymorphism analysis (Figure 4C). This
analysis showed an extra band in the 25-RA DNA, con-
firming that these cells are heterozygous for a mutation
in the amplified region.
To demonstrate that SCAP(D443N) stimulates the
cleavage of SREBPs and to determine whether it acts
at site 1 or 2, we tested the ability of the protein to
stimulate the cleavage of wild-type and mutant forms
of SREBP-2 in cells that were treated with sterols. Plas-
mids encoding SCAP(D443N) and an epitope-tagged
version of SREBP-2 were introduced into 293 cells by
transfection, and the amount of the nuclear NH2-terminal
fragment of SREBP-2 was measured by immunoblotting
with an antibody against the NH2-terminal epitope tag
(Figure 5). As expected, 25-HC caused the NH2-terminal
fragment to disappear from the nuclear extract (upper
panel, lane 4). SCAP(D443N) prevented this disappear-
ance (lane 6). In this experiment, we also observed a
small amount of the membrane-bound intermediate
form that results from cleavage at site 1 but not site 2
Identical residues in at least two of the three sequences are high-
lighted in black. The dot over codon 816 in the hamster sequence
denotes a DNA polymorphism (GGG/AGG; glycine/arginine) found
in wild-type CHO-7 and CHO-K1 cells. The asterisk at codon 443
in the hamster SCAP sequence denotes the mutation in the 25-RA
cells (GAC→AAC; Asp→Asn). Boxed sequences denote WD repeats;
X’s denote the most highly conserved residues (Neer et al., 1994).
Sequences for human K1AA0199 (Nagase et al., 1996; GenBank
accession number D83782) and C. elegans D2013.8 (Wilson et al.,
1994; GenBank accession number 247808) were obtained from the
Figure 3. Amino Acid Sequences of Hamster SCAP, Human indicated reference. GenBank accession number for hamster SCAP
KIAA0199, and C. elegans D2013.8 is U67060.
A Membrane Protein That Stimulates SREBP Cleavage
419
Figure 5. SCAP(D443N) Accelerates Cleavage of SREBP-2 at Ste-
rol-Regulated Site in Transfected 293 Cells
293 cells were transfectedas described in Experimental Procedures.
Aliquots of a control plasmid pRc/CMV7SB-TK (5 mg/dish; lanes 1
and 2) or the indicated wild-type or mutant plasmid (Hua et al., 1996)
encoding HSV epitope-tagged SREBP-2 (3.5 mg/dish; lanes 3–14)
Figure 4. Identification of Mutation in SCAP Gene in Genomic DNA were cotransfected into 293 cells with 1.5 mg/ml of pCMV-
from 25-RA Cells SCAP(D443N) as indicated. The total amount of DNA was adjusted
to 5 mg/dish by addition of pRc/CMV7SB-TK. Transfected cells were(A) Scheme for PCR amplification of a fragment from hamster SCAP
incubated in either inducing (2 sterols) or suppressing (1 sterols)gene. The asterisk denotes position of the D443N mutation. Primers
medium for 16 hr followed by direct addition to the medium of ALLNare indicated below the map.
(final concentration of 25 mg/ml) for an additional 4 hr, after which(B) PvuI digestion of PCR products amplified from SCAP gene.
cell fractionation was carried out as described (Sakai et al., 1996).Genomic DNA from CHO-K1 (lanes 1 and 2) and 25-RA (lanes 3 and
Aliquots of protein (50 mg of nuclear extract or 60 mg of membranes)4) cells was subjected to PCR with primers 2 and 4 corresponding
were subjected to SDS–PAGE and immunoblot analysis with 0.5 mg/to amino acids 426–432 (59-TGTCTGACTTCTTCCTCCAG-39) and
ml of IgG-HSV•TagTM. Filters were exposed for 1 min. M, P, and I467–473 (59-GCGTGCTGGCCTTCCCACAGG-39), respectively. PCR
denote the mature, precursor, and intermediate forms of SREBP-2,was carried out in 50 mM Tris–HCl (pH 9.1), 16 mM (NH4)2SO4, 3.5
respectively.mM MgCl2, 0.15 mg/ml of bovine serum albumin, 125 mM dNTP, 100
nM primers, and 0.5 mCi/ml [32P]dCTP with 0.1 U/ml of Klentaq
polymerase and 6 3 1024 U/ml of Pfu polymerase at 958C for 5 min, ability to stimulate cleavage of the R519A mutant of
followed by 30 cycles at 948C for 30 s, 628C for 30 s, and 728C for
SREBP-2, which fails to undergo cleavage at site 1,30 s. Aliquots of the PCR products were incubated at 378C for 24
owing to the elimination of the lumenal arginine (laneshr in the absence or presence of PvuI, as indicated. The treated
13 and 14). Considered together, the data of Figure 5DNA was separated on a 7% polyacrylamide gel containing 10%
glycerol and exposed to film for 7 hr at room temperature. strongly suggest that SCAP(D443N) acts by enhancing
(C) Single-strand conformational polymorphism analysis. Genomic cleavage at site 1.
DNA from CHO-K1 (lanes 1 and 2) and 25-RA (lanes 3 and 4) cells To compare the ability of wild-type SCAP (SCAP–wt)
was amplified by PCR as described in (B) with primers 1 and 3,
and SCAP(D443N) to stimulate cleavage of SREBP-1except that the annealing temperature was 618C. Primer 1 corre-
and -2, we performed the experiment shown in Figure 6.sponds to codons 417–423 (59-TTCTGCCTCTTTGCTGTTGTG-39),
Varying amounts of plasmids encoding epitope-taggedand primer 3 is derived from an intron sequence located between
codons 448 and 449 (59-CTCCCATGTCTGAAGAGAGC-39). Aliquots versions of wild-type or mutant SCAP were transfected
of the PCR products were denatured by heating at 1008C for 5 min into 293 cells together with a plasmid encoding epitope-
in the presence of formamide and applied to an 8% polyacrylamide tagged SREBP-1a or SREBP-2. The epitope tag was
gel containing 10% glycerol (lanes 2 and 4) adjacent to aliquots of
derived from the herpes simplex virus (HSV) glycopro-the nondenatured samples (lanes 1 and 3). The gel was subjected
tein, and SREBPexpression was driven by the thymidineto electrophoresis at 300 volts for 22 hr at room temperature, dried,
kinase (TK) promoter, which gives a low level of expres-and exposed to film for 10 hr at 2708C. The amplified 162 bp PCR
product contained 96 bp of the SCAP cDNA sequence, followed by sion that is similar to the amount normally expressed in
66 bp of the intron sequence. Arrows denote single-strand DNA these cells (Hua et al., 1996). The cells were incubated in
from wild-type or mutant (D443N) SCAP gene. the presence of 25-HC, and the amounts of the epitope-
tagged NH2-terminal fragments in the nuclear extract
were measured (Figure 6, upper panels). We also esti-
(lower panel, lane 3). This intermediate was abolished mated the amount of expressed SCAP by immunoblot-
by sterols (lane 4), and SCAP(D443N) prevented this ting with an antibody against the T7 epitope tag (lower
disappearance (lane 6). We also studied the D468 panels). Expression of both SCAPs was driven by the
RSR→AS mutant of SREBP-2, which is resistant to weak TK promoter, thereby allowing us to compare the
cleavage at site 2 (Sakai et al., 1996). SCAP(D443N) effects of graded amounts of SCAP–wt and SCAP
stimulated cleavage of this mutant at site 1, and the (D443N). At a low level of SCAP expression (0.05 mg
resultant intermediate form accumulated in the mem- of plasmid transfected), SCAP(D443N) was much more
brane fraction (lower panel, lanes 9 and 10) but not in potent than SCAP–wt in increasing the amount of nu-
clear SREBP-1a or -2 (Figures 6A and 6B, upper panels).the nucleus (upper panel). SCAP(D443N) had much less
Cell
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Figure 6. Comparison of SREBP Cleavage-
Stimulating Activity of Wild-Type and Mutant
SCAP(D443N) in Transfected 293 Cells
On day 2 of growth, 293 cells were cotrans-
fected with either 4.8 mg of pTK-HSV-BP1a
(Hua et al., 1996) encoding HSV epitope-
tagged SREBP-1a (A) or 4.8 mg of pTK-HSV-
BP2 (B) and the indicated amount of plasmid
encoding T7 epitope-tagged SCAP–wt or
SCAP(D443N). The total amount of DNA was
adjusted to 5 mg/dish with pTK (Hua et al.,
1996). All cells were cultured under sup-
pressing conditions (1 mg/ml of 25-HC plus
10 mg/ml of cholesterol). On day 3, the cells
were treated with ALLNfor 4 hr before harvest
and fractionation as described in Figure 5. Aliquots of protein (50 mg of nuclear extract or 60 mg of membranes) were subjected to SDS–PAGE
and immunoblotted with either 0.5 mg/ml of IgG-HSV•TagTM directed against epitope-tagged SREBP-1a and -2 (top) or 1 mg/ml of IgG-T7•TagTM
antibody directed against SCAP (bottom), followed by 0.5 mCi/ml of 125I-labeled sheep anti-mouse whole antibody (Amersham). Filters were
exposed for 16 hr to an imaging plate at room temperature and scanned in a Fuji X Bas 1000 Phosphoimager and the image photographed.
Similar results were obtained in two other independent experiments.
This was true even though the level of expression of encoding either wild-type or mutant SCAP under control
wild-type and mutant SCAP were similar, as judged by of the TK promoter. Both plasmids also encoded neo,
immunoblotting against the T7 epitope tag (lower pan- a gene that confers G418 resistance. The cells were
els). At higher levels of SCAP expression, SCAP–wt then grown in the presence of G418 to select for
showed distinct activity, especially in stimulating the transfected cells. A set of 12 independent colonies of
cleavage of SREBP-1a (Figure 6A, lanes 5 and 7). Never- survivors were plated in individual wells and grown in
theless, the mutant SCAP remained more potent, even medium containing lipoprotein-deficient serum plus 0.3
at the highest amount of plasmid (0.2 mg). Scanning of mg/ml of 25-HC. After 6 days, all of the cells that were
the filters in a Fuji Phosphoimager indicated that at the transfected with the control plasmid died (Figure 8, left
lowest level of SCAP expression (0.05 mg of plasmid panel). Half of the 12 colonies transfected with the
transfected), the SCAP(D443N) mutant was greater than SCAP–wt plasmid survived (middle panel), whereas all
10-fold more potent than SCAP–wt in stimulating cleav- of the 12 colonies transfected with the mutant
age of both SREBPs. At higher levels of expression, the SCAP(D443N) plasmid survived (right panel). We con-
relative difference declined to 3–4-fold. clude that overexpression of either SCAP–wt or SCAP
We next attempted to determine whether SCAP–wt
participates in the normal cleavage of SREBPs that oc-
curs in the absence of sterols. For this purpose, we used
a strategy in which we overexpressed the SREBPs by
transfection with a plasmid containing the strong CMV
promoter. We have shown previously that such overex-
pressed SREBPs are cleaved inefficiently, apparently
owing to the saturation of a rate-limiting component
(Hua et al., 1996). To determine whether that component
is SCAP, we cotransfected cDNAs encoding wild-type
SCAP or SCAP(D443N) together with a plasmid encod-
ing epitope-tagged SREBP-2 under control of the CMV
promoter. As shown in Figure 7, in the absence of SCAP,
there was relatively little mature form of SREBP-2 in the
nuclear extract either in the absence or presence of
sterols (upper panel, lanes 1 and 2). Coexpression of
SCAP–wt led to a marked stimulation of cleavage in the
absence of sterols (lane 3), and there was only a slight
Figure 7. SCAP–Stimulated Cleavage of Overexpressed SREBP-2inhibition by 25-HC (lane 4). Coexpression of SCAP
in Transfected 293 Cells
(D443N) gave a somewhat greater degree of stimulation
Aliquots of pCMV-HSV-BP2 (3 mg/dish) encoding HSV epitope-
in the absence of sterols (lane 5), and there was no tagged SREBP-2 driven by the CMV promoter were cotransfected
suppression by 25-HC (lane 6). SCAP–wt and SCAP into 293 cells with 2 mg/dish of a control plasmid pRc/CMV7SB-TK
(D443N) both caused a large increase in the intermediate (lanes 1 and 2), wild-type pCMV-SCAP (lanes 3 and 4), or mutant
form of SREBP-2 that remained in the membrane pellet pCMV-SCAP(D443N) (lanes 5 and 6), as indicated. Transfected cells
were incubated in either inducing (2 sterols) or suppressing(lower panel). We attribute this to saturation of the site
(1 sterols) medium for 16 hr followed by direct addition to the2 cleavage enzyme by the large amounts of intermediate
medium of 25 mg/ml ALLN for an additional 4 hr before harvest andformed, owing to the stimulation of the site 1 cleavage
fractionation. Aliquots of protein (40 mg of nuclear extract or 60 mg
reaction by SCAP. of membranes) were subjected to SDS–PAGE and immunoblotted
To confirm that SCAP is capable of conferring resis- with 0.5 mg/ml of IgG-HSV•TagTM. Filters were exposed to film for
tance to the lethal effects of 25-HC, we transfected wild- 1 s. P, I, and M denote the precursor, intermediate, and mature
forms of SREBP-2, respectively.type CHO cells with a control plasmid or a plasmid
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ER by means of a hydrophobic NH2-terminal domain of
approximately 339 amino acids (Liscum et al., 1985)
that is currently believed to contain eight membrane-
spanning regions (Olender and Simoni, 1992; Roitelman
et al., 1992). A segment of HMG CoA reductase that
includes membrane-spanning regions 2–6 shows 25%
identity and 55% similarity to a corresponding region in
the hydrophobic domain of SCAP (residues 280–444).
The resemblance includes the hydrophilic loops be-
tween membrane-spanning regions 3–4 and 4–5 of HMG
CoA reductase. Asp-443 of SCAP is included in the re-
gion of resemblance, but its position is occupied by a
Figure 8. 25-HC Resistance of CHO-7 Cells Transfected with Wild- valine in HMG CoA reductase.
Type and Mutant SCAP(D443N) The database search also revealed that the hydro-
On day 0, CHO-7 cells were set up at 5 3 105 cells/100 mm dish in philic carboxy-terminal domain of SCAP contained four
medium B supplementedwith 5% newborn calf lipoprotein-deficient copies of a motif called the WD repeat (Neer et al., 1994).
serum. On day 1, the cells were transfected with 10 mg/dish of a
These are indicated in Figure 3, and their significancecontrol plasmid pTK (Hua et al., 1996; left), wild-type plasmid pTK-
is discussed below.HSV-SCAP-T7 (middle), or mutant plasmid pTK-HSV-SCAP-
T7(D443N) (right), using an MBS Kit (Stratagene). The cells were
incubated with DNA for 3 hr in a 5% CO2 incubator at 358C and then
refed with medium B with 5% newborn calf lipoprotein-deficient Discussion
serum. On day 3, the cells were switched to medium containing 700
mg/ml of G418. The medium was changed every 2–3 days. On day 16, In the current studies, we used an expression-cloning
individual colonies were isolated with cloning cylindersand grown in
technique to isolate a cDNA encoding a superactiveG418-containing medium for 28 days. On day 44, cells from individ-
mutant version of SCAP from a line of CHO cells that isual colonies were plated into 12 well plates at a density of 2.5 3
resistant to transcriptional suppression by 25-HC. The104 cells/well in medium B containing 700 mg/ml of G418. On day
45, the medium was switched to medium B (without G418) supple- approach was based on the previousdemonstration that
mented with 5% newborn calf lipoprotein-deficient serum and 0.3 the defect in the mutant cells (25-RA cells) is genetic-
mg/ml of 25-HC. The medium was changed every 2–3 days. On day ally dominant when these cells are fused to wild-type
51, cells were fixed in 95% ethanol, stained with crystal violet, and
CHO cells (Hasan and Chang, 1994). The expression-photographed.
cloning strategy made use of the observation that 25-
HC suppresses luciferase activity in human 293 cells
transfected with a luciferase cDNA under control of a(D443N) can protect cells against lethal suppression by
25-HC. promoter containing multiple copies of SRE-1. A trans-
fected pool of cDNAs from the25-RA cells was observedA hydropathy plot of the sequence of hamster SCAP
revealed that the NH2-terminal 800 residues contained to block this sterol-mediated repression, and the re-
sponsible cDNA was isolated by repeated fractionationmultiple long hydrophobic segments of at least 20 resi-
dues each (Figure 9A). We estimate that these segments of the pool.
The mutant SCAP differs from SCAP–wt by virtue ofmight specify up to 10 membrane-spanning regions. The
sequence also contains five potential N-linked glycosyl- a G→A transition at codon 443, which changes the Asp
codon to Asn. In transient transfection experiments, mu-ation sites that are indicated by the arrows in Figure
9A. To confirm the postulated membrane localization of tant SCAP prevented 25-HC from suppressing cleavage
of wild-type SREBP-1a and -2. It also stimulated theSCAP, we transfected 293 cells with an HSV epitope-
tagged version of SCAP(D443N), and the cells were cleavage of the D484RSR→AS mutant of SREBP-2, but
not the R519A mutant, indicating that SCAP stimulatesfractionated into crude nuclear extract, cytosol, and
membrane fractions. The fractions were subjected to cleavage at the first sterol-regulated site.
In experiments to be reported in detail elsewhereSDS–polyacrylamide gel electrophoresis (SDS–PAGE)
and immunoblotting with the antibody against the HSV (Nohturfft et al., 1996), we observed the identical G→A
transition at codon 443 of SCAP in two other CHO cellepitope tag. All of the tagged SCAP was found in the
membrane fraction (Figure 9B). Similar results were ob- lines that were mutagenized and selected for 25-HC
resistance. Byhaplotype analysis, we showed that thesetained with wt–SCAP.
In a search of databases for proteins that resembled mutations were indeed independent because they oc-
curred on different parental chromosomes. We believe,SCAP, we found a significant resemblance to HMG CoA
reductase, an ER–bound enzyme of the cholesterol bio- therefore, that theD443N substitution is a highly specific
event that endows SCAP with the ability to resist 25-synthetic pathway (Goldstein and Brown, 1990). A simi-
lar relationship had been noted by Wilson et al. (1994) HC inhibition.
In the presence of 25-HC, SCAP–wt stimulated thewith the C. elegans SCAP homolog, whose function was
then unknown. Figure 9C compares the sequences of cleavage of SREBP-1a and -2. At very low levels of
expression, the D443N mutant was at least 10-fold morehamster SCAP and hamster HMG CoA reductase in the
areas of highest identity. The catalytic component of potent than the wild-type, but at high levels of expres-
sion the difference diminished. The difference nearlyHMG CoA reductase consists of approximately 548
amino acids at the carboxy-terminus of the protein (Lis- disappeared when SCAP expression was driven by the
CMV promoter, which gives much higher expressioncum et al., 1985). It is bound to the membranes of the
Cell
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Figure 9. Hydropathy Plot of Amino Acid Sequence of SCAP, Its Cellular Distribution, and Sequence Resemblance with HMG CoA Reductase
(A) The residue-specific hydropathy index was calculated over a window of 20 residues by the method of Kyte and Doolittle (1982), using the
Genetics Computer Group Sequence Analysis Software Package, Version 8.0 (Devereux et al., 1984). Arrows denote potential N-linked
glycosylation sites. The solid bar denotes a region that resembles homology to transmembrane domains 2–6 in mammalian HMG CoA reductase
(see [C]).
(B) 293 cells were transfected with 5 mg/dish of either pBluescript II SK (lanes 1–3) or pTK-HSV-SCAP-T7(D443N), an HSV epitope-tagged
plasmid encoding SCAP(D443N) (lanes 4–6). Transfected cells were incubated in medium A supplemented with 10% fetal calf serum for 16
hr and fractionated into nuclear extract, cytosol, and membrane fractions as described (Sakai et al., 1996). Aliquots of protein from transfected
cells (40 mg for nuclear extract, lanes 1 and 4; 60 mg for cytosol, lanes 2 and 5; and 60 mg for membrane fraction, lanes 3 and 6) were subjected
to SDS–PAGE and immunoblot analysis with 0.5 mg/ml of IgG-HSV•TagTM antibody. The filter was exposed to film for 30 s.
(C) Identical residues are highlighted in black. Similar residues are denoted by an asterisk. Overbars denote position of membrane-spanning
regions 2–6 in Chinese hamster HMG CoA reductase (Liscum et al., 1985; Olender and Simoni, 1992). The sequence for HMG CoA reductase
(GenBank accession number 123341) was from Chin et al. (1984).
than the TK promoter (data not shown). We believe that the reaction at least partially resistant to inhibition by 25-
HC. The sterol resistance may be attributable to massivethe 10-fold difference observed at low levels of expres-
sion represents the true difference in potency of the two SCAP overexpression. If sterols inhibit SCAP activity
by less than 100%, the residual SCAP activity in theproteins at their usual level of expression in cells. This
difference accounts for the ability of 25-RA cells, but overexpressing cells may be sufficient to activate
SREBP cleavage even in the presence of sterols. Thenot CHO-7 cells, to grow in the presence of 25-HC.
A role for SCAP–wt in the normal processing of D443N mutation renders the SCAP reaction resistant to
inhibition by sterols, even at low physiologic levels ofSREBPs is suggested by the experiment of Figure 7.
When we overexpressed SREBP-2by transfection under SCAP expression, thereby explaining the sterol resis-
tance phenotype of the 25-RA cells.control of the strong CMV promoter, the protein was
cleaved inefficiently, suggesting that a required compo- The hypothesis that SCAP is a normal part of the
sterol-sensing machinery is supported by the finding ofnent had become rate-limiting. When we overexpressed
either SCAP–wt or SCAP(D443N), cleavage was stimu- sequence resemblance between the hydrophobic re-
gions of SCAP and HMG CoA reductase. The originallated, both in the absence and presence of sterols. A
possible explanation is that cleavage of SREBPs nor- cloning of HMG CoA reductase revealed that the protein
was divided into two regions (Chin et al., 1984). Themally requires SCAP and that sterols block cleavage of
SREBPs by inhibiting the activity of SCAP. When catalytic domain at the carboxy-terminus is anchored
to the membranes of the ER by a hydrophobic NH2-SREBPs are overexpressed, SCAP becomes saturated,
and therefore cleavage is inefficient. Overexpression of terminal domain that was originally postulated to contain
seven transmembrane segments (Liscum et al., 1985).SCAP–wt restores efficient cleavage, and it also renders
A Membrane Protein That Stimulates SREBP Cleavage
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More recent data indicates that the true number is eight It is also possible that SCAP, like the b subunit of the
heterotrimeric G proteins, interacts with a GTP–binding(Olender and Simoni, 1992; Roitelman et al., 1992). When
the catalytic region was expressed as a truncated pro- protein that is part of the regulatory system.
tein lacking the membrane anchor, the protein was solu-
ble in the cytosol, and it restored growth to HMG CoA Experimental Procedures
reductase-deficient CHO cells, indicating that the mem-
Luciferase Assay Systems and b-Galactosidase Assay Kits werebrane domain is not required for catalysis (Gil et al.,
purchased from Promega and Stratagene, respectively. The 25-RA1985). Rather, the function of the hydrophobic domain
cell line was provided by T. Y. Chang (Dartmouth Medical School).
is to render the degradation of HMG CoA reductase Total cellular RNA was isolated by guanidine thiocyanate/cesium
sensitive to regulation by sterols (Gil et al., 1985). In chloride centrifugation (Chirgwin et al., 1979). Poly(A)1 RNA was
sterol-deprived CHO cells, the full-length enzyme was isolated with an mRNA Purification Kit (Pharmacia Biotech). Plasmid
pSVb, encoding an SV40 promoter-driven b-galactosidase reporterdegraded with a half-life of 5 hr. Sterols reduced the half-
gene, was obtained from Clontech. An SRE-1–driven luciferase re-life to 1.5 hr. In cells expressing the truncated soluble
porter plasmid containing, 59 to 39, three tandem copies of Repeatcatalytic domain, the half-life of the enzyme was greater
2 1 3 of the LDL receptor promoter, the adenovirus E1b TATA box,
than 10 hr, and there was no effect of sterols. In more and the luciferase gene was provided to us by Steven McKnight
recent studies, Kumagai et al. (1995) have used HMG (Tularik, Inc.). This reporter plasmid, designated pSRE-Luc, was
CoA reductase–b-galactosidase fusion proteins to show constructed by PCR amplification of Repeat 2 1 3 of Plasmid K
(Briggs et al., 1993) and insertion of the PCR product into pGL2-that several of the membrane-spanning segments are
Basic (Promega), a plasmid containing the luciferase gene. Otherrequired in order for sterols to accelerate the degrada-
materials were obtained from sources as described (Hua et al.,tion of HMG CoA reductase. The required segments
1996).
include the ones that resemble the putative membrane-
spanning segments in SCAP. Cell Culture, Transfection, and Fractionation of Cells
The sequence resemblance between the hydrophobic All cells were grown in monolayer at 378C in an atmosphere of
regions of SCAP and HMG CoA reductase raises the 8%–9% CO2. Human embryonic kidney 293 cells were maintained
in medium A (Dulbecco’s modified Eagle’s medium containing 100possibility that this region inSCAP isalso a sterolsensor.
U/ml of penicillin and 100 mg/ml of streptomycin sulfate) supple-We do not believe that this sequence imparts sterol-
mented with 10% (v/v) fetal calf serum. Stock cultures of CHO-K1regulated degradation toSCAP, since we found noeffect
cells (ATCC, catalog number CCL-61) and CHO-7 cells, a clone
of sterols on the amount of epitope-tagged SCAP–wt of CHO-KI cells adapted to growth in lipoprotein-deficient serum
or SCAP(D443N) protein in transfected cells. Rather, the (Metherall et al., 1989), were grown in medium B (a 1:1 mixture
interaction of sterols with the hydrophobic region of of Ham’s F-12 medium and Dulbecco’s modified Eagle’s medium
containing 100 U/ml of penicillin and 100 mg/ml of streptomycinSCAP may inhibit its ability to stimulate the cleavage of
sulfate) supplemented with either 5% fetal calf serum (CHO-KI cells)SREBPs.
or 5% newborn calf lipoprotein-deficient serum (CHO-7 cells). 25-It is possible that SCAP is the sterol-regulated prote-
RA cells (Chang and Limanek, 1980) were grown in medium B sup-
ase that cleaves SREBPs at site 1, even though we did plemented with 5% newborn calf lipoprotein-deficient serum and 1
not find any known protease motifs in its sequence. mg/ml of 25-HC.
More likely, SCAP is a regulator of the protease, perhaps For metabolic experiments, 293 cells were set up and transfected
with the indicated plasmid, using an MBS Transfection Kit (Stra-through direct protein–protein interactions. This hypoth-
tagene) as described (Hua et al., 1995). After transfection (3 hr,esis is favored by the finding that the carboxy-terminal
358C, 3% CO2 incubator), the cells were incubated with medium Ahydrophilic domain of SCAP contains four WD repeats,
containing 50 mM compactin, 50 mM sodium mevalonate, 5% fetal
which are indicated in Figure 3. WD repeats are a loosely calf lipoprotein-deficient serum, under inducing conditions (no ste-
conserved set of sequences that conform to theconsen- rols) or suppressing conditions (1 mg/ml of 25-HC plus 10 mg/ml
sus [GH-X23-41-WD]. In some cases, the GH can be re- of cholesterol). Cell homogenates were fractionated into a nuclear
extract and a 105 g membrane pellet as described (Hua et al., 1996).placed by AH, as in the second and fourth copies in
SCAP (Figure 3). The WD can sometimes be replaced
Expression Cloning of Mutant SCAPby FR, as in the second repeat in SCAP. The WD repeats
from 25-RA–Derived mRNAalso frequently contain a conserved D, as indicated by
The parent vector used for the cDNA expression library was derivedthe X over repeats 2–4 in SCAP (Figure 3). A set of four
from pSREBP-1, a CMV promoter–driven plasmid containing the
to eight copies of the WD repeat is found in at least hamster SREBP-1 sequence (Sato et al., 1994). After removal of the
27 different proteins with varying functions. Neer et al. SREBP-1 cDNA sequence from pSREBP-1 by SalI–NotI digestion,
(1994) have called attention to the fact that most such a 1.4 kb SalI–NotI fragment containing the HSV TK promoter was
cloned into the parent vector to generate pRc/CMV7SB-TK. The 1.4proteins are regulatory and none is an enzyme. They
kb fragment was removed by SalI–NotI digestion prior to ligation ofhave speculated that WD repeats are involved in pro-
cDNAs into the SalI–NotI sites. NotI-oligo(dT)-primed cDNA that hadtein–protein interactions.
been synthesized from poly(A)1 RNA (5 mg) from 25-RA cells was
The prediction of Neer was confirmed by Sondek et size-selected by gel filtration, ligated to SalI adapters, and cloned
al. (1996) and Wall et al. (1995), who determined the into the SalI–NotI-digested parent vector using the SuperScriptTM
three-dimensional structure of the b subunit of hetero- Plasmid System (GIBCO-BRL). A portion of the ligation mixture was
electroporated into competent Escherichia coli ElectroMAXtrimeric G proteins. The b subunit contains seven WD
DH10BTM cells (GIBCO-BRL), yielding a directional cDNA library withrepeats that are folded to form a circularized 7-fold b
greater than 106 independent recombinants. Approximately 320propeller. In Gia1b1g2, blades of the WD propeller interact pools of plasmids (approximately 1 3 103 independent cDNAs per
with the Gia1 subunit and the g2 subunit, thereby bridging pool) were grown overnight in 50 ml cultures of Luria-Bertani me-
the heterotrimeric complex (Wall et al., 1995). It is tempt- dium. Prior to transfection, plasmid DNA was purified using Qiagen-
ing to speculate that the WD repeats of SCAP interact tip 100 columns (Qiagen, Inc.).
Pools of cDNAs in pRc/CMV7SB were transfected into 293 cellswith and regulate SREBP, the site 1 protease, or both.
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simultaneously with cDNAs encoding an SRE-1–driven luciferase Construction of Expression Plasmids
A TK promoter–driven expression plasmid encoding an epitope-reporter gene (pSRE-Luc) anda control b-galactosidase gene driven
by an SV40 promoter (pSVb). On day 0, replicate wells of 6 3 104 tagged version of mutant SCAP, designated pTK-HSV-SCAP-
T7(D443N), was constructed in two steps: first, pTK-HSV-BP2 (Huacells/22 mm well were plated in medium A with 10% fetal calf serum.
On day 2, duplicate wells of cells were each cotransfected by the et al., 1996) was digested with BspDI and XbaI to isolate a 6 kb
fragment containing two tandem copies of the HSV epitope tagcalcium phosphate method with an MBS Kit (Stratagene) with the
following plasmids: 1.32 mg of the cDNA pool of plasmids; 0.2 mg upstream of the BspDI site. pCMV-SCAP(D443N) was digested with
BstEII and XbaI to isolate a 3.6 kb fragment encoding amino acidsof pVA, a plasmid encoding adenovirus VA RNA1, which enhances
expression of transfected cDNAs (Yokoyama et al., 1993); 0.36 mg 151–1276 of SCAP. A pair of primers, 59-GAAATCGATACCCTGACT
GAAAGGCTGCGT-39 corresponding to amino acids 2–8 and 59-AACof the SRE-1–driven luciferase reporter construct; and 0.12 mg of
pSVb in a final volume of 200 ml. After transfection (3 hr), the cells TTGGCATGGTAGCGCTG-39 corresponding to amino acids 241–
246, was used to amplify the NH2-terminus of SCAP by PCR ofwere washed once with phosphate-buffered saline and fed with 2
ml of medium A supplemented with 10% newborn calf lipoprotein- pCMV-SCAP(D443N), using described conditions (Hua et al., 1995).
The resultant PCR product was digested with BspDI and BstEII todeficient serum, 50 mM compactin, 50 mM sodium mevalonate, 1
mg/ml of 25-HC, and 10 mg/ml of cholesterol. After 16 hr, the cells isolate a 447 bp fragment. The above three fragments were ligated
to generate an intermediate construct encoding an initiator methio-in each well were lysed with 250 ml of 1X Reporter Lysis Buffer
(Promega), and aliquots were used for measurement of luciferase nine, followed by two tandem copies of the HSV epitope tag (Hua
et al., 1996), followed by two novel amino acids (ID) that correspond(5 ml) and b-galactosidase (30 ml) activities. For luciferase assay,
photon production was detected as relative light units in an Optima to the BspDI restriction site, followed by amino acids 2–1276 of
SCAP(D443N). Second, the above intermediate construct was di-II Luminometer (MGM Instruments). For b-galactosidase assay, hy-
drolysis of O-nitrophenyl b-D-galactopyranoside was detected after gested with BspDI and BstYI to isolate a 3.6 kb fragment containing
amino acids 2–1195 of SCAP(D443N). pTK-HSV-BP2-T7, which con-incubation for 1 hr at 378C in a Microplate Reader at a wavelength
of 405 nm (Bio-Tek Instruments). The amount of luciferase activity tains three tandem copies of the T7 epitope tag sequence at the
carboxy-terminus (provided by Elizabeth Duncan), was digestedin transfectants (relative light units) was normalized to the amount
of b-galactosidase activity (O.D. units). with BspDI and NdeI to isolate a 6 kb fragment that contained
the T7 epitope repeats but not the sequence of SREBP-2. A pairThe normalized values for luciferase activity (relative light units/
O.D. units), in monolayers transfected with the vast majority of plas- of primers, 59-TACAGCAGCAGCAACACAGT-39 corresponding to
amino acid residues 1057–1063 of SCAP and 59-GCTAGCCATATGAmid cDNA pools, were about 2,000. In a screen of 235 pools of 1,000
cDNAs each, a single pool gave a normalized value approximately GCTGCGTCCAGTTTCTCCAGCACAGA-39 corresponding to amino
acid residues 1270–1276 of SCAP, was used to amplify the carboxy-5-fold higher than the background value of 2,000 and was consid-
ered positive (Figure 3). The DNA from this positive pool, number terminus of SCAP. The resulting PCR product was digested with
BstYI and NdeI, and a 253 bp fragment encoding amino acids 1196–60, was transformed into E. coli DH5a cells to generate multiple
pools of approximately 100 independent transformants per pool. 1276 of SCAP was isolated. The three isolated fragments were li-
gated to generate pTK-HSV-SCAP-T7(D443N).The plasmid pools were transfected into 293 cells, which were as-
sayed for expression of luciferase and b-galactosidase activities. A TK promoter–driven expression plasmid encoding an epitope-
tagged version of wild-type SCAP, designated pTK-HSV-SCAP-T7,Plasmid DNA from one positive pool was retransformed into E. coli
to generate multiple pools of about 10 transformants perpool. These was constructed by replacing the 1.8 kb BstEII–BsmBI fragment of
pTK-HSV-SCAP-T7(D443N) encoding amino acids 151–763 with theplasmid pools were transfected into 293 cells. The plasmids from
one positive pool were further divided into five cDNAs per pool corresponding fragment from pSCAP (described above). The se-
quence of codon 443 was confirmed by DNA sequencing to be wild-before transfection and then assayed. Finally, individual cDNAs were
used to transfect 293 cells, and two positive clones were identified, type.
A CMV promoter–driven expression plasmid encoding wild-typep28 and p30. Subsequent studies were carried out with clone p30,
which encodes the mutant form of SCAP and is hereafter designated SCAP was constructed in three steps: first, pCMV-SCAP(D443N)
(described above in “Expression Cloning”) was digested with SalI–pCMV-SCAP(D443N). A set of two fragments generated from pCMV-
SCAP(D443N) after digestion with SalI–NotI, 2.9 kb and 1.3 kb, were DraI, and the resulting 4.1 kb insert containing SCAP(D443N) was
subsequently cloned into the XhoI–EcoRV sites of pcDNA3 to gener-cloned into pBluescript II SK(1) and sequenced on both strands
with T7/T3 primers or specific internal primers. ate intermediate construct I. Second, intermediate construct I was
digested with BamHI–BstEII, and the resulting fragment encoding
amino acids 1–150 of SCAP was used to replace the BamHI–BstEIIcDNA Cloning of Wild-Type SCAP
fragment from pcDNA3-clone 4 (described above) that lacked theA double-stranded bacteriophage library was constructed from poly
sequence of the first 56 amino acids of SCAP–wt to generate inter-(A)1 RNA isolated from CHO-7 cellsusing the DirectionalRH Random
mediate construct II. Third, intermediate construct II was digestedPrimer cDNA Library Construction System (Novagen). cDNAs from
with BamHI and BsmBI, and the resulting 2.4 kb fragment was usedthe first two fractions of the gel filtration column provided in the kit
to replace amino acids 1–763 of SCAP(D443N) between SalI–BsmBIwere ligated into the EcoRI–HindIII arms of l Phage and plated out
sites in pCMV-SCAP(D443N), yielding a construct expressing wild-on E. coli ER1647. Approximately 5 3 105 plaques were transferred
type SCAP, designated pCMV-SCAP. The sequence at codon 443to replicate filters and probed with a 32P-labeled 2.9 kb SalI–NotI
was verified by DNA sequencing.DNA fragment from pCMV-SCAP(D443N). One clone, designated
A CMV promoter–driven expression plasmid encoding humanclone 4, contained an insert of 3.9 kb and was sequenced on both
SREBP-2 was constructed by cloning a 4.1 kb SpeI–XbaI fragmentstrands. This clone lacked the sequence encoding the first 56
encoding the HSV epitope-tagged SREBP-2 fusion protein of 1157amino acids of SCAP. Clone 4 was digested with BamHI–PmeI and
amino acids from pTK-HSV-BP2 (Hua et al., 1996) into the EcoRV–cloned into the BamHI–EcoRV sites of pcDNA3 (Invitrogen) to gener-
XbaI sites of pcDNA3. This plasmid is designated pCMV-HSV-BP2.ate an intermediate construct, pcDNA3-Clone 4. To construct the
entire coding sequence of wild-type SCAP, we amplified the se-
quence encoding wild-type SCAP from CHO-7 cells by reverse PCR of Genomic DNA and Single-Strand
Conformational Polymorphism Analysistranscription–PCR with a primer pair corresponding to nucleo-
tides 59-GACTCAGTCGACAGGGGAAAGGTACCTGCAGA-39 from Genomic DNA from wild-type and 25-RA cells was isolated with a
DNA extraction kit (Stratagene). Primers flanking the point mutationthe 59-untranslated region and 59-CTGAGTTACGTAAGGTCCAAAG
AATTGCTGCC-39 from the 39-untranslated region of pCMV-SCAP at codon 443 of the SCAP gene were used to amplify genomic DNA
by PCR. Single-strand conformational polymorphism analysis of(D443N). The PCR–amplified product was digested with SalI and
BsmI to isolate an approximately 500 bp fragment encoding the genomic DNA was carried out as described by Orita et al. (1989).
PCR products were cloned into a pCRTMII vector (Invitrogen) or afirst 121 amino acids of SCAP. This fragment was ligated into the
BamHI–BsmI site of pcDNA3-Clone 4 to generate a wild-type version pNoTA/T7 vector (5 Prime → 3 Prime, Inc.) and sequenced to verify
the mutation.of SCAP, designated pSCAP.
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Immunoblot Analysis Evans, M.J.,and Metherall, J.E. (1993). Loss of transcriptionalactiva-
tion of three sterol-regulated genes in mutant hamster cells. Mol.Proteins were transferred from an 8% SDS–polyacrylamide gel to
Hybond-C extra nitrocellulose (Amersham) and blotted with one of Cell. Biol. 13, 5175–5185.
the following antibodies: IgG-7D4, a mouse monoclonal antibody Gil, G., Faust, J.R., Chin, D.J., Goldstein, J.L., and Brown, M.S.
directed against the NH2-terminus of hamster SREBP-2 (amino acids (1985). Membrane-bound domain of HMG CoA reductase is required
32–250; Yang et al., 1995), IgG-2A4, a monoclonal antibody against for sterol-enhanced degradation of the enzyme. Cell 41, 249–258.
the basic–helix-loop-helix domain of human SREBP-1 (Sato et al., Goldstein, J.L., and Brown, M.S. (1990). Regulation of the mevalo-
1994), IgG-HSV•TagTM, a monoclonal antibody against the glycopro- nate pathway. Nature 343, 425–430.
tein D epitope of HSV (Novagen), and IgG-T7•TagTM, a monoclonal
Goldstein, J.L., Hobbs, H.H., and Brown, M.S. (1995). Familial hyper-antibody against an epitope in the T7 major capsid protein (Nova-
cholesterolemia. In The Metabolic and Molecular Bases of Inheritedgen). Unless otherwise stated, bound antibodies were stained with
Disease, C.R. Scriver, A.L. Beaudet, W.S. Sly, and D. Valle, eds.the Enhanced Chemiluminescence Western Blotting Detection Kit
(New York: McGraw-Hill, Inc.), pp. 1981–2030.(Amersham) as described (Hua et al., 1995), except that Luminol/
Hasan, M.T., and Chang, T.Y. (1994). Somatic cell genetic analysisEnhancer Solution and Stable Peroxide Solution (Pierce) were used.
of two classes of CHO cell mutants expressing opposite phenotypesGels were calibrated with prestained molecular mass markers (New
in sterol-dependent regulation of cholesterol metabolism. Som. CellEngland Biolabs), and the filters were exposed to ReflectionTM film
Mol. Genet. 20, 481–491.(DuPont/NEN) at room temperature for the indicated times.
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